Illumina, Inc. (NASDAQ:ILMN), announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing.
The Home Depot Foundation announced a commitment of up to $1 million to support immediate disaster relief and long-term recovery efforts in the communities impacted by the devastating tornado outbreak across the central United States.
Implementation of co-beneficial land-use practices around solar power arrays improves upon sustainable energy development in a practice known as ‘agrivoltaics’.
At Bayer, we’re committed to reducing greenhouse gas emissions in major agricultural markets by 30% by the year 2030. And how will we get there? By enlisting the help of farmers and tapping into a climate-smart solution farmers know well— soil.
Last week, our Fall River Operations team provided turkeys to the local United Way to distribute to multiple families.
Today, The Toronto-Dominion Bank ("TD" or the "Bank") closed a three-year US$500 million green bond offering through a syndicate of underwriters that includes minority-, women- and veteran-owned business enterprises (MWVBEs).
Sovereign bond ratings are high-impact numbers: defining the interest rate a country has to pay for debt and fresh capital. Comparison of conventionally overeign bond ratings and ESG country credit ratings based on the Global Sustainable Competitiveness Index (GSCI show significant differences.
In the Season 3 finale of the Pro Bono Perspectives podcast, host and Common Impact CEO Danielle Holly highlights three ways you can be a force for good in the new year.
SCS Global Services announces it has achieved “Best Verification Company” in Environmental Finance’s 2021 Annual Market Rankings, a peer-voted market survey. This award signifies the company’s dedication to rigorous validation and verification of offset projects, so that its clients can deliver high-quality verified carbon credits to the global markets.
Increasing diversity in clinical trials (DiCT) is imperative to improve the health of populations around the world.